Gaucher

Gauch·er

(gō-shā'),
Philippe C.E., French physician, 1854-1918. See: Gaucher cells, Gaucher disease, pseudo-Gaucher cell.
References in periodicals archive ?
Shire Announces European Approval of VPRIV (velaglucerase alfa) for the Treatment of Type 1 Gaucher Disease
The audit was performed as part of the Ministry of Health's evaluation of the company's manufacturing process of taliglucerase alfa for the treatment of Gaucher disease.
Drug developer Shire Plc (Basingstoke UK) said its potential Gaucher disease drug showed positive results in a late-stage study.
The National Gaucher Foundation (NGF) was established in 1984 as a nonprofit organization dedicated to supporting and promoting research into the causes of Gaucher Disease.
Gaucher disease is a relentless progressive multi-systemic disorder caused by deficiency or inadequate function of lysosomal ?
Andy Gaucher was driving his family around Northumberland when he came across the accident and knew he had to act quickly.
Gaucher disease is a rare, hereditary disease caused by lack of a lysosomal enzyme.
Gaucher disease is an inborn error of glycosphingolipid metabolism resulting from a deficiency of the lysosomal enzyme [beta]-glucosidase (1,2).
TKT is conducting a clinical trial in Israel of its investigational gene-activated glucocerebrosidase (GA-GCB) for the treatment of Gaucher disease.
The shrubs in this memorable planter were the burgundy barberry (Berberis Thunbergii Atropurpurea) and Abelia grandiflora Eduard Gaucher.